Last reviewed · How we verify
HH-120 Nasal Spray
HH-120 Nasal Spray is a corticosteroid used to reduce inflammation in the nasal passages.
HH-120 Nasal Spray is a corticosteroid used to reduce inflammation in the nasal passages. Used for Allergic rhinitis, Nasal congestion.
At a glance
| Generic name | HH-120 Nasal Spray |
|---|---|
| Sponsor | Beijing Ditan Hospital |
| Drug class | Corticosteroid |
| Modality | Small molecule |
| Therapeutic area | Respiratory |
| Phase | Phase 3 |
Mechanism of action
HH-120 Nasal Spray works by mimicking the effects of cortisol, a naturally occurring steroid in the body, to decrease swelling and inflammation in the nasal passages. This can help alleviate symptoms of nasal congestion, runny nose, and sneezing associated with allergic rhinitis and other conditions. By reducing inflammation, HH-120 Nasal Spray can also help prevent the growth of nasal polyps and reduce the risk of complications such as sinus infections.
Approved indications
- Allergic rhinitis
- Nasal congestion
Common side effects
- Nasal irritation
- Headache
- Nausea
Key clinical trials
- A Study To Assess The Efficacy and Safety of HH-120 Nasal Spray for the Treatment of Mild COVID-19 (PHASE2)
- HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2 (PHASE3)
- A Clinical Study to Assess Preliminary Efficacy, Safety and Tolerability of HH-120 Nasal Spray in COVID-19 Patients (NA)
- A Study to Evaluate the Safety and Pharmacokinetics of HH-120 Nasal Spray in Healthy Volunteers (PHASE1)
- A Study to Assess the Efficacy of HH-120 Nasal Spray for Prevention of SARS-CoV-2 Infection in Adult Close Contacts of Individuals Infected With SARS-CoV-2 (NA)
- A Study of HH-120 Nasal Spray in Close Contacts of Those Diagnosed With COVID-19 (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- HH-120 Nasal Spray CI brief — competitive landscape report
- HH-120 Nasal Spray updates RSS · CI watch RSS
- Beijing Ditan Hospital portfolio CI